Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Genzyme Corp drug CAPRELSA appeared first …
New patent expiration for Genzyme Corp drug CAPRELSA Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from three suppliers. There are five patents…
The post New patent for Boehringer Ingelheim drug PRADAXA appeared …
New patent for Boehringer Ingelheim drug PRADAXA Read Post »
Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on DrugPa…
Annual Drug Patent Expirations for LEVULAN Levulan is a drug marketed by Dusa and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for DUSA drug LEVULAN appeared first on DrugPatentWatch – M…
Annual Drug Patent Expirations for XOFLUZA Xofluza is a drug marketed by Genentech Inc and is included in two NDAs. It is available from two suppliers. There are six patents…
The post New patent for Genentech Inc drug XOFLUZA appeared first on DrugPate…
This chart shows the pharmaceutical companies with the most patents in Mexico. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Mexico? Read Post »
Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. There is one…
The post New patent for Pacira Pharms drug EXPAREL appeared first on DrugPatentWatch…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Austria. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Austria? Read Post »
CAPRELSA (vandetanib) Genzyme corp Patent: 7,173,038 Expiration: Aug 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…
Drug Patent Expirations for the Week of August 8, 2021 Read Post »
Get new actionable insights and updates from BiotechBlog
